In the study by Dobias et al., the involvement of Asp-IgG and IgA test assay could improve IPA diagnosis in non‐neutropenic patients by increasing the sensitivity and negative predictive value when combined with the GM or (1,3)‐β‐d‐glucan assays [12]. This evidence concerns the gene CD79A and Ito hypomelanosis.